Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
84 Views
Favorite
0
Like
Facebook
Tweet
Print
Email
Resident Poster
(10-244) Use of Omalizumab for the Treatment of Refractory Bullous Pemphigoid with Concomitant Risankizumab Therapy for Psoriasis
Wednesday, December 11, 2024
11:00 AM – 12:00 PM
Location: Hall G, Lower Level
Category:
Case Report
Topic:
Drug Information/Drug Use Evaluation
Co-Author(s):
Oriol Corral Magaña, Júlia Pardo Pastor, Nuria Meca Casasnovas, Neus Curcó Botargues
Primary Author(s)
Fernando Salazar Gonzalez, PharmD